HERANTIS PHARMA
Herantis Pharma A pharmaceutical company targeting unmet clinical needs.
HERANTIS PHARMA
Social Links:
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
2008-01-01
Address:
Helsinki, Southern Finland, Finland
Country:
Finland
Website Url:
http://www.herantis.com
Total Employee:
1+
Status:
Active
Contact:
+358 9 222 1195
Total Funding:
16.07 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Current Employees Featured
Founder
Stock Details
Investors List
Broadview Ventures
Broadview Ventures investment in Series A - Herantis Pharma
Official Site Inspections
http://www.herantis.com Semrush global rank: 8.64 M Semrush visits lastest month: 274
- Host name: fi-p1.seravo.net
- IP address: 95.217.73.56
- Location: Finland
- Latitude: 60.1717
- Longitude: 24.9349
- Timezone: Europe/Helsinki
More informations about "Herantis Pharma"
Herantis Pharma - Crunchbase Company Profile & Funding
Herantis Pharma successfully completed a directed share issue, raising EUR 5.2 million to fund the development of HER-096 and other corporate purposes.See details»
Herantis Pharma - Corporate Governance
Herantis Pharma Plc is a public Finnish limited liability company, which complies with the Finnish Companies Act, Securities Market Act, Finnish Accounting standards (FAS), the rules of …See details»
Herantis Pharma - Johtoryhmä
CSO Henri Huttunen co-founded Herantis Pharma Plc. in 2008 and served as the company’s founding CEO for the first two years. Dr. Huttunen is currently the Chief Scientific Officer of …See details»
Herantis Pharma Plc. Information - RocketReach
Herantis Pharma Plc. is a Biotechnology Research, Manufacturing General, and Biotechnology company located in Espoo, Uusimaa with $1 million in revenue and 22 employees. Find top …See details»
Org Chart Herantis Pharma - The Official Board
The org chart of Herantis Pharma contains its 8 main executives including Antti Vuolanto and Tone Kvale.See details»
Herantis Pharma Plc. | LinkedIn
Herantis Pharma Plc is an innovative biotech company developing disease modifying therapies for Parkinson’s disease. Herantis' lead product HER-096, is an advanced small and synthetic …See details»
Herantis Pharma - VentureRadar
Herantis Pharma is a publicly listed (HRTIS) drug development company aiming to revolutionize the treatment of diseases with unmet clinical needs. Based on leading academic research …See details»
Henri Huttunen, Herantis Pharma | Careers in Discovery
Jan 23, 2025 In this episode of Careers in Discovery, Emma sits down with Henri Huttunen, Chief Scientific Officer at Herantis Pharma, a Finnish biotech developing ground-breaking …See details»
Herantis Pharma initiates non-invasive CDNF development
Jul 6, 2018 Herantis Pharma Plc ("Herantis") announced today the initiation of a non-invasive CDNF development program to broaden the application of CDNF in Parkinson's disease and …See details»
Non-invasive CDNF for Parkinson's Being Developed, …
Jul 10, 2018 Herantis Pharma is launching a development program for non-invasive cerebral dopamine neurotrophic factor (CDNF) as a treatment candidate for patients with Parkinson’s disease.See details»
Herantis's Parkinson's Therapy Passes Preliminary Trial Safety...
Feb 20, 2018 Read about an independent trial review board finding that Herantis's Parkinson’s therapy CDNF is safe. This means the Phase 1/2 study can continue.See details»
Herantis Pharma | Lymphatic Education & Research Network
Herantis’ Lymfactin® is the world’s first and only clinical stage gene therapy that repairs damages of the lymphatic system. It expresses the human growth factor VEGF-C, which is natural and …See details»
Herantis Announces Inconclusive Results from Phase II Study with ...
Company release, inside information, 2 March 2021 at 2:00 p.m. Eastern European Time Herantis Pharma Plc (“Herantis”), an innovative clinical stage biotech company pioneering new disease …See details»
Herantis: uutta tutkimustietoa - Inderes
Sep 20, 2024 Herantis julkaisi torstaina lehdistötiedotteen koskien uutta tieteellistä julkaisua, joka liittyy hermostoa suojaavan CDNF-proteiinin toimintamekanismiin.See details»
Herantis Pharma participating at Alzheimer’s & Parkinson’s Drug ...
Tärkeimmät ajankohtaiset talousuutiset, pörssikurssit ja kattavat sijoittajapalvelut löydät Kauppalehdestä.See details»
HRPMF: Dividend Date & History for Herantis Pharma OYJ
Home Dividend Stocks Health Care Biotech Pharma Specialty Pharma Herantis Pharma OYJ (HRPMF)See details»
Herantis Pharma Announces Successful HER-096 Initial Results …
Mar 24, 2022 Herantis Pharma Plc is an innovative biotech company developing disease modifying therapies for Parkinson’s Disease. Herantis lead product HER-096, is an advanced …See details»
Herantis Pharma Oyj Stock Price Today - Investing.com
View today's Herantis Pharma Oyj stock price and latest HRTIS news and analysis. Create real-time notifications to follow any changes in the live stock price.See details»
Herantis Pharma - Hermorappeumasairauksien pysäyttäjä
Jan 3, 2025 Mitä ajatuksia ja kysymyksiä Herantis Pharmasta? Herantis ei ole meillä Inderesillä seurannassa, mutta yhtiön toimitusjohtaja Pekka Simula on lupautunut tulla aika ajoin tänne …See details»